S. Thayer

发表

ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice.

R. Charnigo, A. Daugherty, D. Rateri, 2009, American journal of physiology. Heart and circulatory physiology.

Angiotensin II Infusion Promotes Abdominal Aortic Aneurysms Independent of Increased Blood Pressure in Hypercholesterolemic Mice

R. Charnigo, A. Daugherty, D. Rateri, 2009 .

Frequency and costs of pulmonary exacerbations in patients with cystic fibrosis in the United States

P. Hodgkins, M. Schechter, J. Wagener, 2017, Current medical research and opinion.

The Direct Cost of Managing a Rare Disease: Assessing Medical and Pharmacy Costs Associated with Duchenne Muscular Dystrophy in the United States.

C. McDonald, C. Bell, S. Thayer, 2017, Journal of managed care & specialty pharmacy.

The INITIATOR Study: Pilot Data on Real-World Clinical and Economic Outcomes in US Patients with Type 2 Diabetes Initiating Injectable Therapy

R. Cuddihy, W. Crown, E. Buysman, 2013, Advances in Therapy.

Etanercept treatment patterns in managed-care patients with psoriasis or psoriatic arthritis

D. Globe, D. Harrison, C. Watson, 2010, Journal of medical economics.

Generation Matters: The Nexus of Nativity, Identity, and Fertility Among Hispanic Women in the United States

S. Thayer, 2017 .

Impact of osteoporosis on high-cost chronic diseases.

G. Gomez Rey, B. Stolshek, J. Seare, 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Real-world comparison of treatment patterns and effectiveness of albiglutide and liraglutide.

E. Buysman, A. Joshi, M. Bogart, 2018, Journal of comparative effectiveness research.

Adherence to a Fixed-Dose Combination of Rosiglitazone/Glimepiride in Subjects Switching from Monotherapy or Dual Therapy with a Thiazolidinedione and/or a Sulfonylurea

B. Arondekar, C. Harley, T. Darkow, 2010, The Annals of pharmacotherapy.

Real-world evaluation of glycemic control among patients with type 2 diabetes mellitus treated with canagliflozin versus dipeptidyl peptidase-4 inhibitors

R. Aguilar, S. Korrer, W. Chow, 2016, Current medical research and opinion.

An Unbreakable Bond: Linking Mothers and Newborns in Large, De-Identified Claims Database

G. Bandoli, S. Thayer, Nina Veeravalli, 2019 .

Using a Claims-Based Framework to Identify Severe Maternal Morbidities in a Commercially Insured US Population

O. Ameli, C. Chaisson, L. Genen, 2021, The Journal of perinatal & neonatal nursing.

HbA1c Outcomes in Patients Treated With Canagliflozin Versus Sitagliptin in US Health Plans.

R. Aguilar, S. Korrer, W. Chow, 2017, Clinical therapeutics.